{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:43:39Z","timestamp":1791755019641,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd008214.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000}}],"reference-count":98,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008214.pub3","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T12:22:08Z","timestamp":1438950128000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy"],"prefix":"10.1002","volume":"2015","author":[{"given":"Jonathan M","family":"Smith","sequence":"first","affiliation":[{"name":"Sunderland Eye Infirmary; Queen Alexandra Road Sunderland UK SR2 9HP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David HW","family":"Steel","sequence":"additional","affiliation":[{"name":"Sunderland Eye Infirmary; Queen Alexandra Road Sunderland UK SR2 9HP"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD008214.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ophtha.2009.07.001","article-title":"Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial","volume":"116","author":"Ahmadieh","year":"2009","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD008214.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.ophtha.2011.03.036","article-title":"The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy","volume":"118","author":"Ahn","year":"2011","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00417-010-1303-3","article-title":"Intravitreal bevacizumab for the surgical treatment of severe proliferative retinopathy","volume":"248","author":"Lauro","year":"2010","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0004|cit4","first-page":"709","article-title":"Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy","volume":"2","author":"Batarny","year":"2008","journal-title":"Clinical Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0005|cit5","article-title":"Outcome of a single intravitreal bevacizumab injection on the visual acuity and course of pars plana vitrectomy in proliferative diabetic retinopathy","author":"Elwan","journal-title":"Current Eye Research"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/IAE.0b013e31820a68e5","article-title":"Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage","volume":"31","author":"Farahvash","year":"2011","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/112067211002000604","article-title":"Experience with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy","volume":"20","author":"Hern\u00e1ndez-Da Mota","year":"2010","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0008|cit8","article-title":"Randomized controlled study of intravitreal bevacizumab 0.16 mg injected one day before surgery for proliferative diabetic retinopathy","author":"Manabe","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/112067210901900526","article-title":"Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy","volume":"19","author":"Modarres","year":"2009","journal-title":"European Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","article-title":"Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)","volume":"246","author":"Rizzo","year":"2008","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archophthalmol.2012.1611","article-title":"Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1","volume":"130","author":"Sohn","year":"2012","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0012|cit12","first-page":"590","article-title":"Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy","volume":"29","author":"Zaman","year":"2013","journal-title":"Pakistan Journal of Medical Science"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000314721","article-title":"Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series","volume":"45","author":"Abdelhakim","year":"2011","journal-title":"Ophthalmic Research"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/08820538.2013.835847","article-title":"The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage","volume":"30","author":"Berk Ergun","year":"2015","journal-title":"Seminars in Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaophthalmol.2014.287","article-title":"Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy","volume":"132","author":"Bhavsar","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/IAE.0b013e3181d6def0","article-title":"Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage","volume":"30","author":"Cheema","year":"2010","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.2008.151233","article-title":"Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)","volume":"93","author":"R Lucena D","year":"2009","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/OED.S12352","article-title":"Effect of bevacizumab injection before vitrectomy on intravitreal hemorrhage in pseudophakic patients with proliferative diabetic retinopathy","volume":"5","author":"Demir","year":"2013","journal-title":"Ophthalmology and Eye Diseases"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0019|cit19","first-page":"310","article-title":"The effect on surgical success of intravitreal bevacizumab given before pars plana vitrectomy in diabetic patients","volume":"18","author":"Doganay","year":"2010","journal-title":"Retina-Vitreus"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5301\/ejo.5000327","article-title":"The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage","volume":"24","author":"Goncu","year":"2014","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0021|cit21","first-page":"252","article-title":"Preoperative intravitreal bevacizumab improves visual outcome in diabetic vitreous surgery","author":"Gupta","year":"2008","journal-title":"American Academy of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/eye.2011.321","article-title":"Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study","volume":"26","author":"Gupta","year":"2012","journal-title":"Eye"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10792-012-9541-5","article-title":"Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab","volume":"32","author":"Gupta","year":"2012","journal-title":"International Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.eye.6702983","article-title":"Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy","volume":"23","author":"Ishikawa","year":"2009","journal-title":"Eye"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008214.pub3-BIB0025|cit25","first-page":"S136","article-title":"Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study","volume":"95","author":"Jirawison","year":"2012","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0026|cit26","first-page":"261","article-title":"Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy","volume":"3","author":"Li","year":"2010","journal-title":"International Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/IAE.0b013e3181a8eb88","article-title":"Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (Avastin)","volume":"29","author":"Lo","year":"2009","journal-title":"Retina"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0028|cit28","unstructured":"NCT01589718 A phase III randomized 1:1, masked, study of the safety, tolerability, and efficacy of intravitreal pre-op 0.3mg pegaptanib sodium versus sham, for adjuvant management of TRD and vit hem associated with PDR clinicaltrials.gov\/show\/NCT01589718"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ophtha.2008.11.005","article-title":"Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment","volume":"116","author":"Oshima","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3928\/23258160-20141118-06","article-title":"A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy","volume":"45","author":"Pakzad-Vaezi","year":"2014","journal-title":"Ophthalmic Surgery Lasers and Imaging Retina"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00417-009-1247-7","article-title":"Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study","volume":"248","author":"Park","year":"2010","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/eye.2011.149","article-title":"Bevacizumab prior to vitrectomy for diabetic traction retinal detachment","volume":"28","author":"Pokroy","year":"2011","journal-title":"Eye"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/eye.2008.354","article-title":"Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?","volume":"23","author":"Romano","year":"2009","journal-title":"Eye"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/112067210901900416","article-title":"Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?","volume":"19","author":"Romano","year":"2009","journal-title":"European Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/0974-9233.106387","article-title":"Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy","volume":"20","author":"Sato","year":"2013","journal-title":"Middle East African Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajo.2008.04.028","article-title":"Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy","volume":"146","author":"Yang","year":"2008","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/IAE.0b013e3181a3b7ef","article-title":"Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy","volume":"29","author":"Yeh","year":"2009","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1442-9071.2008.01805.x","article-title":"Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series","volume":"36","author":"Yeoh","year":"2008","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1755-3768.2008.01498.x","article-title":"Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment","volume":"88","author":"Yeung","year":"2010","journal-title":"Acta Opthalmologica"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0040|cit40","unstructured":"ISRCTN79120387 A randomised, single-masked, phase IV pilot study of the efficacy and safety of adjunctive intravitreal Avastin\u00ae (bevacizumab) in the prevention of early postoperative vitreous haemorrhage following diabetic vitrectomy www.controlled-trials.com\/ISRCTN79120387"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0041|cit41","unstructured":"NCT00516464 Evaluation of ranibizumab in proliferative diabetic retinopathy (PDR) requiring vitrectomy clinicaltrials.gov\/ct2\/show\/NCT00516464"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0042|cit42","unstructured":"NCT00931125 Randomized, double blinded, controlled, two-center study assessing the safety and efficacy of intravitreal ranibizumab as a preoperative adjunct treatment before vitrectomy surgery in proliferative diabetic retinopathy (PDR) compared to vitrectomy alone clinicaltrials.gov\/show\/NCT00931125"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0043|cit43","unstructured":"NCT01091896 Adjuvant intravitreal bevacizumab in pars plana vitrectomy for vitreous hemorrhage secondary to diabetic retinopathy clinicaltrials.gov\/show\/NCT01091896"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0044|cit44","unstructured":"NCT01151722 Adjuvant intravitreal bevacizumab in pars plana vitrectomy for diabetic vitreous hemorrhage clinicaltrials.gov\/show\/NCT01151722"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0045|cit45","unstructured":"NCT01306981 A prospective, randomised controlled trial of ranibizumab pre-treatment in diabetic vitrectomy - a pilot study clinicaltrials.gov\/show\/NCT01306981"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0046|cit46","unstructured":"NCT01805297 Intravitreal aflibercept injection as a surgical adjuvant in severe proliferative diabetic retinopathy clinicaltrials.gov\/show\/NCT01805297"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0047|cit47","unstructured":"NCT01854593 Prospective randomized controlled study of intravitreal injection of 0.16 mg bevacizumab one day before surgery for proliferative diabetic retinopathy clinicaltrials.gov\/show\/NCT01854593"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0161-6420(85)34002-2","article-title":"Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1","volume":"92","author":"Anonymous","year":"1985","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub3-BIB0049|cit49","first-page":"862","article-title":"Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients","volume":"19","author":"Benson","year":"1988","journal-title":"Ophthalmic Surgery"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0161-6420(00)00213-X","article-title":"Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage","volume":"107","author":"Bhende","year":"2000","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0161-6420(86)33791-6","article-title":"Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy","volume":"93","author":"Blankenship","year":"1986","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archopht.1986.01050140149039","article-title":"Fluid-gas exchange and photocoagulation after vitrectomy. Indications, technique, and results","volume":"104","author":"Blumenkranz","year":"1986","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archopht.1992.01080160084037","article-title":"Reoperation following diabetic vitrectomy","volume":"110","author":"Brown","year":"1992","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0054|cit54","unstructured":"Diabetes UK Diabetes:facts and stats www.diabetes.org.uk\/Documents\/About%20Us\/Statistics\/Diabetes-key-stats-guidelines-April2014.pdf"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/IAE.0b013e31817d5be3","article-title":"Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial","volume":"28","author":"Faghihi","year":"2008","journal-title":"Retina"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0056|cit56","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0057|cit57","unstructured":"Macmasters University Computer program on www.gradepro.org"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00006982-199111030-00007","article-title":"Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage. Long-term results and complications","volume":"11","author":"Han","year":"1991","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ophtha.2003.08.043","article-title":"Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings","volume":"111","author":"Hershberger","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0060|cit60","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0039-6257(92)90137-I","article-title":"Vitrectomy in the management of diabetic eye disease","volume":"37","author":"Ho","year":"1992","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006982-200001000-00010","article-title":"Ultrasound biomicroscopy for examination of the sclerotomy site in eyes with proliferative diabetic retinopathy after vitrectomy","volume":"20","author":"Hotta","year":"2000","journal-title":"Retina"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0161-6420(89)32649-2","article-title":"Hemostatic effects of air versus fluid in diabetic vitrectomy","volume":"96","author":"Joondeph","year":"1989","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9394(99)00322-0","article-title":"One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy","volume":"129","author":"Kaiser","year":"2000","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"102","author":"Klein","year":"1984","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years","volume":"102","author":"Klein","year":"1984","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0420.2001.079001034.x","article-title":"Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage","volume":"79","author":"Koutsandrea","year":"2001","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00006982-199313040-00012","article-title":"Wound complications in pars plana vitrectomy","volume":"13","author":"Kreiger","year":"1993","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00139341","article-title":"Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients","volume":"10","author":"Laatikainen","year":"1987","journal-title":"International Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0070|cit70","first-page":"2","article-title":"A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010","volume":"12","author":"Liew","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0002-9394(14)74219-9","article-title":"Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy","volume":"103","author":"Liggett","year":"1987","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9394(14)71858-6","article-title":"Efficacy of fluid-air exchange for postvitrectomy diabetic vitreous hemorrhage","volume":"114","author":"Martin","year":"1992","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0073|cit73","first-page":"133","article-title":"The role of vitrectomy in diabetic retinopathy","volume":"18","author":"Mason","year":"1978","journal-title":"International Ophthalmology Clinics"},{"issue":"Pt 2","key":"10.1002\/14651858.CD008214.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/eye.1991.40","article-title":"Microsurgical management of neovascularisation secondary to posterior segment ischaemia","volume":"5","author":"McLeod","year":"1991","journal-title":"Eye"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bjo.84.8.810","article-title":"Entry site neovascularisation after diabetic vitrectomy","volume":"84","author":"McLeod","year":"2000","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0161-6420(02)01872-9","article-title":"Wieger's ligament [republished in Ophthalmology. 2003 Jun;110(6):1265]","volume":"110","author":"McLeod","year":"2003","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(84)34099-4","article-title":"Vitreous hemorrhage after vitrectomy for diabetic retinopathy","volume":"91","author":"Novak","year":"1984","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0161-6420(89)32686-8","article-title":"Procoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. A prospective, randomized study","volume":"96","author":"Packer","year":"1989","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bjo.2004.062638","article-title":"Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial","volume":"89","author":"Ramezani","year":"2005","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub3-BIB0080|cit80","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0021-5155(99)00194-X","article-title":"Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy","volume":"44","author":"Sawa","year":"2000","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/jms.2008.008015","article-title":"The English national screening programme for sight threatening diabetic retinopathy","volume":"15","author":"Scanlon","year":"2008","journal-title":"Journal of Medical Screening"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0161-6420(83)34540-1","article-title":"Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications","volume":"90","author":"Schachat","year":"1983","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ophtha.2006.08.017","article-title":"Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes","volume":"114","author":"Schiff","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0161-6420(96)30697-0","article-title":"Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment","volume":"103","author":"Schwatz","year":"1996","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ophtha.2007.08.034","article-title":"Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography","volume":"115","author":"Steel","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0161-6420(89)32700-X","article-title":"Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy","volume":"96","author":"Tolentino","year":"1989","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/09286586.2014.906628","article-title":"Rate of diabetic vitrectomy in a defined geographical part of North East England","volume":"21","author":"Vaideanu","year":"2014","journal-title":"Ophthalmic Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD008214.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"e6052","DOI":"10.5867\/medwave.2014.11.6052","article-title":"Does preoperative intravitreal bevacizumab reduce complications of vitrectomy for proliferative diabetic retinopathy?","volume":"14","author":"Veliz","year":"2014","journal-title":"Medwave"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3928\/1542-8877-20010501-04","article-title":"Postoperative complications following vitrectomy for proliferative diabetic retinopathy with sew-on and noncontact wide-angle viewing lenses","volume":"32","author":"Virata","year":"2001","journal-title":"Ophthalmic Surgery and Lasers"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bjo.84.8.822","article-title":"Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy","volume":"84","author":"West","year":"2000","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ophtha.2006.07.047","article-title":"Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy","volume":"114","author":"Yang","year":"2007","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ophtha.2005.07.010","article-title":"Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study","volume":"112","author":"Yeh","year":"2005","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bjo.2007.124495","article-title":"Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy","volume":"92","author":"Yorston","year":"2008","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2013.02.008","article-title":"Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials","volume":"156","author":"Zhang","year":"2013","journal-title":"American Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/bjo.2010.189514","article-title":"A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy","volume":"95","author":"Zhao","year":"2011","journal-title":"British Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008214.pub2","article-title":"Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","author":"Smith","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub3-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008214","article-title":"Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","author":"Steel","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008214.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008214.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T12:15:58Z","timestamp":1718021758000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008214.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":98,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008214.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008214.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]}}}